1-Isopropyl-1'-[(2-methyl-1H-benzimidazol-6-yl)carbonyl]-1,4-dihydrospiro[indazole-5,4'-piperidin]-7(6H)-one(CAS: 1301214-47-0)

This compound would fall under various regulatory guidelines such as the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) for hazardous communication, REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) in the European Union for registration and restriction, and the Toxic Substances Control Act (TSCA) in the United States. Specific hazard categories and classification should be determined based on its physical and chemical properties.

Alternatives to this compound in synthesis include other benzimidazole derivatives or related spiro compounds. Common alternative reagents might include 2-methylbenzimidazole or other piperidine derivatives, depending on the desired product profile and reaction conditions.

The market and research trends for this compound are likely driven by its potential use in pharmaceuticals, specifically as an intermediate in drug development, due to its structural features. Research is ongoing to explore its biological activity and potential therapeutic applications.

Waste containing this compound should be collected in appropriate containers, labeled with the correct hazard information, and disposed of according to local regulations. Incineration is a common method for disposal, but professional waste disposal services are recommended to ensure compliance with environmental protection standards.